A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)

  • Dan P. Zandberg
  • , Sandra Rollins
  • , Olga Goloubeva
  • , Robert E. Morales
  • , Ming Tan
  • , Rodney Taylor
  • , Jeffrey S. Wolf
  • , Lisa M. Schumaker
  • , Kevin J. Cullen
  • , Ann Zimrin
  • , Robert Ord
  • , Joshua E. Lubek
  • , Mohan Suntharalingam
  • , John C. Papadimitriou
  • , Dean Mann
  • , Scott E. Strome
  • , Martin J. Edelman

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science